GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Veradigm MDRX · USD

Health Care · US listing · 🇺🇸 United States

Compare

4.75

-1.04%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Veradigm annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In USD.

FY2024FY2022FY2021FY2020FY2019
Revenue$588.0m$588.0m$577.4m$1.50bn$1.63bn
Operating income−$27.1m−$19.6m$75.7m−$57.7m−$99.7m
Net income−$86.5m−$86.5m$134.4m$700.4m−$182.2m
Free cash flow$83.3m$83.3m−$77.3m−$123.7m−$81.7m
Total assets$1.50bn$1.50bn$2.43bn$2.92bn$3.21bn
Shareholders' equity$1.02bn$1.02bn$1.41bn$1.67bn$1.29bn

Revenue by business

Year to 31 Dec 2022

  • Provider [Member] $465.9m · 79.2%
  • Payer and Life Science [Member] $122.1m · 20.8%
  • Payer & Life Sciences [Member] $122.1m · 20.8%

Revenue by region

Year to 31 Dec 2022

  • UNITED STATES $588.0m · 100.0%

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.